U.S. Physical Therapy (NYSE:USPH) Earns Outperform Rating from Barrington Research

U.S. Physical Therapy (NYSE:USPH)‘s stock had its “outperform” rating reiterated by investment analysts at Barrington Research in a research note issued on Thursday, Benzinga reports. They currently have a $108.00 target price on the stock. Barrington Research’s target price points to a potential upside of 12.63% from the company’s current price.

Several other brokerages have also commented on USPH. StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. Bank of America restated a “neutral” rating and set a $90.00 price target (down from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th.

U.S. Physical Therapy Stock Performance

U.S. Physical Therapy stock opened at $95.89 on Thursday. The firm has a 50 day simple moving average of $83.21 and a 200-day simple moving average of $91.53. The stock has a market cap of $1.45 billion, a price-to-earnings ratio of 90.46, a price-to-earnings-growth ratio of 3.93 and a beta of 1.38. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.88 and a quick ratio of 1.88. U.S. Physical Therapy has a 1-year low of $76.18 and a 1-year high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing the consensus estimate of $0.82 by ($0.09). The business had revenue of $167.19 million during the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period last year, the company earned $0.76 EPS. On average, analysts expect that U.S. Physical Therapy will post 2.58 EPS for the current year.

Insiders Place Their Bets

In related news, Director Kathleen A. Gilmartin purchased 2,000 shares of the business’s stock in a transaction on Tuesday, September 3rd. The shares were bought at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the acquisition, the director now directly owns 18,904 shares in the company, valued at $1,627,445.36. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, COO Graham D. Reeve sold 1,724 shares of the company’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the transaction, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at approximately $580,635. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Kathleen A. Gilmartin purchased 2,000 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was acquired at an average cost of $86.09 per share, with a total value of $172,180.00. Following the completion of the acquisition, the director now directly owns 18,904 shares of the company’s stock, valued at $1,627,445.36. This represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On U.S. Physical Therapy

Large investors have recently modified their holdings of the stock. Norden Group LLC boosted its holdings in shares of U.S. Physical Therapy by 37.5% during the first quarter. Norden Group LLC now owns 4,528 shares of the company’s stock worth $511,000 after purchasing an additional 1,235 shares during the last quarter. BNP Paribas Financial Markets increased its position in shares of U.S. Physical Therapy by 6.8% during the first quarter. BNP Paribas Financial Markets now owns 7,837 shares of the company’s stock worth $885,000 after acquiring an additional 502 shares during the last quarter. GSA Capital Partners LLP boosted its stake in U.S. Physical Therapy by 110.3% during the 1st quarter. GSA Capital Partners LLP now owns 7,909 shares of the company’s stock valued at $893,000 after acquiring an additional 4,149 shares during the last quarter. Texas Permanent School Fund Corp grew its position in shares of U.S. Physical Therapy by 1.3% in the 1st quarter. Texas Permanent School Fund Corp now owns 13,116 shares of the company’s stock worth $1,480,000 after acquiring an additional 170 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. bought a new stake in shares of U.S. Physical Therapy during the 1st quarter valued at about $391,000.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.